Upcoming Event | 纳迪尔·阿尔伯教授论新冠疫情时代的希望

大学 作者:广东以色列理工学院 2021-12-24 21:53:49


科技领军人物系列讲座

为帮助广以师生了解更加丰富的学术界前沿资讯,获得更多与专家学者近距离交流的机会,广东以色列理工学院推出“GTIIT-Technion科技领军人物系列讲座”,为广以师生带来精彩的学术盛宴。


点击下方链接可回顾前两场GTIIT-Technion科技领军人物系列讲座:

Lecture Review | 赵东元院士与广以师生畅谈科学之美

Lecture Review | 诺奖得主开讲新冠疫情与伦理问题


“GTIIT-Technion科技领军人物系列讲座”即将迎来第三位重磅嘉宾——来自以色列特拉维夫大学的纳迪尔·阿尔伯教授。他是内科、胃肠病学、健康促进和癌症预防专家,目前带领其团队开展抗新冠肺炎药物“EXO-CD24”的研发及进行多期临床实验的项目。


纳迪尔·阿尔伯教授将分别从科普和学术的视角,为我们带来以“EXO-CD24-新冠疫情时代的希望-从想法到突破性现实的道路”为主题的两场讲座,讲座详情如下:



讲座摘要

有一部分人在感染了严重急性呼吸系统综合症冠状病毒2 (SARS-CoV-2) 后会发展为危及生命的肺炎,以及通常称为免疫风暴的高炎症状态。因此,创新的治疗方法亟需研发。信号转导子CD24是一种高度糖基化的小分子,是锚定在细胞膜上的GPI,在许多信号转导途径中发挥作用。CD24 已被证明通过多种机制在抑制炎症信号中发挥重要作用,尤其是 NFĸB。我们开发了过表达免疫检查点蛋白 CD24 [EXO CD24 (OBCTCD24 Ltd., Israel)] 的外泌体,用于治疗 COVID-19 诱导的免疫过度激活。在此,我们提出了概念验证研究,即服用EXO CD24来抑制细胞因子和趋化因子的产生,从而治疗 COVID-19疾病最重要的并发症。



科普讲座

日期:2021年12月30日(星期四)

时间:19:00-20:00(北京时间)

           13:00-14:00(以色列时间)

地点:广东以色列理工学院北校区科报厅 

讲座语言:英文 (届时将安排线上同传)

Zoom链接:

(1)手机端:请扫描二维码进入科普讲座

(2)PC端:请通过下方网址进入科普讲座https://gtiit.zoom.us/j/97604389435 

学术讲座

日期:2022年1月6日(星期四)

时间:19:00-20:00(北京时间)

           13:00-14:00(以色列时间) 

地点:广东以色列理工学院北校区科报厅

讲座语言:英文(届时将安排线上同传)

Zoom链接:

(1)手机端:请扫描二维码进入学术讲座

(2)PC端:请通过下方网址进入学术讲座

         https://gtiit.zoom.us/j/98011243663 

主讲人介绍


纳迪尔·阿尔伯

博士、理学硕士、医学管理硕士

内科、胃肠病学、健康促进和癌症预防专家

特拉维夫大学萨克勒医学院教授

纳迪尔·阿尔伯是一位杰出的研究员和医师。他改变了以色列癌症预防和管理的模式,在特拉维夫医疗中心建立了第一个综合癌症预防中心,并领导了癌症治疗领域的前沿、开箱即用的转化研究。阿尔伯凭借他的出版物和成就闻名于以色列乃至世界的医疗服务人员。


纳迪尔·阿尔伯是特拉维夫医学中心和特拉维夫大学萨克勒医学院的医学和胃肠病学教授。他是癌症研究的Yechiel and Helen Lieber教授。他于1987年毕业于耶路撒冷哈达萨的医学院,曾在拉宾医学中心(1987-1991年)担任内科住院医师,并在特拉维夫医学中心(1991-1993年)担任胃肠病学研究员。他于1990年完成理学硕士学位,1991年完成工商管理硕士学位。他还在纽约哥伦比亚大学综合癌症中心的Bernard Weinstein博士实验室作为该中心的领导和主任(1993-1996年)获得了三年的研究奖学金。

1999 年,他被提名为胃肠病学系 GI 肿瘤科的负责人。2002 年至 2008 年,他在特拉维夫大学萨克勒医学院担任医学博士论文委员会的负责人。2006 年,他在特拉维夫医疗中心建立了独一无二的综合癌症预防中心。2008 年至 2014 年,他担任特拉维夫大学萨克勒医学院的资助委员会主任。2010-2017年,他任特拉维夫大学癌症研究中心主任。2011 年以来,他担任 Djerassi-Ellias 肿瘤学中心的负责人。2014-2017年,他在特拉维夫大学建立了Dotan血液肿瘤中心。2014年,他当选以色列胃肠学和肝脏病学会主席。2015-2017 年,他担任以色列胃肠病学和肝脏病学会主席。2018 年,他被选为欧洲肿瘤学学会 (ESMO) 癌症预防部门的负责人。





Lecture Series

The "Guangdong-Technion Leadership in Science and Technology Lecture Series" has been held at GTIIT since last month, to provide a platform for high-impact dialogues that explore topics that are pertinent to our faculty, our students, and our community.


Please click the following links for the lectures of this series:

Lecture Review | 赵东元院士与广以师生畅谈科学之美

Lecture Review | 诺奖得主开讲新冠疫情与伦理问题


The next lecture of the "Guangdong-Technion Leadership in Science and Technology Lecture Series" will be delivered by Prof. Nadir Arber of Tel Aviv Medical Center & Tel Aviv University – an expert in the field of cancer prevention. Currently he leads a promising research project related to Covid-19.


Prof. Nadir Arber will present two separate lectures with scientific and popular perspectives respectively, entitled EXO-CD24 - Promise in the Corona Age - the Road From an Idea to a Groundbreaking Reality. EXO-CD24 is an anti-coronavirus drug invented by Prof. Nadir Arber.



Abstract

A small but significant proportion of those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) develop life threatening pneumonia and a hyper-inflammatory state often referred to as the cytokine storm. A great need exists for innovative therapeutic approaches. Signal transducer CD24 is a small heavily glycosylated molecule, that is GPI anchored to the cell membrane, and plays a role in many signal transduction pathways. CD24 has been shown to play a major role in dampening inflammatory signaling via multiple mechanisms, and in particular NFĸB. We have developed exosomes over-expressing immune-checkpoint-protein CD24 [EXO CD24 (OBCTCD24 Ltd., Israel)], to treat COVID-19 induced immune hyper-activation.

Herein, we present proof-of-concept studies that the administration of EXO CD24 targets the most important complication of Covid19 disease by inhibiting the production of cytokines and chemokines.


Popular Lecture

Date: December 30th, 2021 (Thursday)

Time: 19:00-20:00 (Beijing Time)

           13:00-14:00 (Israel Time)

Venue: GTIIT Auditorium

Language: English (Simultaneous interpretation will be available)

Zoom Link:

(1) By mobile phone: please scan the QR code to enter the lecture 

(2) By PC: please visit the website below to enter the lecture

      https://gtiit.zoom.us/j/97604389435


Scientific Lecture

Date: January 6th, 2022 (Thursday)

Time: 19:00-20:00 (Beijing Time)

           13:00-14:00 (Israel Time)

Venue: GTIIT Auditorium

Language: English (Simultaneous interpretation will be available)

Zoom Link:

(1) By mobile phone: please scan the QR code to enter the lecture 

(2) By PC: please visit the website below to enter the lecture

      https://gtiit.zoom.us/j/98011243663 

Prof. Nadir Arber


Nadir Arber 

MD, MSc, MHA

Professor of Medicine and Gastroenterology


Yechiel and Helen Lieber Professor for Cancer Research

Head - Health Promotion Center & Head - Integrated Cancer Prevention Center

Dr. Arber, is an outstanding researcher and physician, expert in internal medicine, gastroenterology, health promotion and cancer prevention. He has changed the landscape of cancer prevention and management in Israel, by establishing the first integrated cancer prevention center at Tel Aviv Medical Center and by leading cutting-edge, out-side of the box, translational research in the field of cancer therapy. Dr. Arber’s world-wide reputation among the health care providers in Israel and in the world, based on his publications and achievements.

 

Nadir Arber (MD, MSc, MHA) is a full Professor of medicine and gastroenterology in Tel Aviv Medical Center and Tel Aviv University, Sackler School of Medicine. He is Yechiel and Helen Lieber Professor for Cancer Research. He had graduated medical school in Hadassah, Jerusalem, in 1987 (graduating Magna Cum Laude). He had done residency in internal medicine in Rabin Medical Center (1987-1991), and fellowship in gastroenterology in the Tel Aviv Medical Center (1991-1993). He had completed his MSc in 1990 and MBA in 1991. He also had three years of research fellowship at the Comprehensive Cancer Center at Columbia University, NY, at the laboratory of Dr. Bernard Weinstein, leader and director of the center (1993-1996).

 

The following are the milestones of his career: In 1999, he was nominated to head the GI Oncology Unit at the department of gastroenterology. In 2002-2008 he had headed the MD thesis committee, at Tel-Aviv University Sackler Medical School. In 2008 – 2014 he had headed the grants committee of the Sackler School of Medicine in Tel Aviv University. In 2006, he established the unique Integrated Cancer Prevention Center at the Tel Aviv Medical Center. From 2010-2017, he became the director of the cancer research center of Tel Aviv University. Since 2011 he is the chief of the Djerassi-Ellias oncology center. In 2014-2017 he established the Dotan hemato-oncology center in Tel Aviv University. In 2014 he was the president elect of the Israeli society of gastroenterology and hepatology. In 2015-2017 he served as the president of the Israeli society of gastroenterology and hepatology. In 2018 he was chosen to lead the cancer prevention section at the European Society of Medical Oncology (ESMO).




文/图:研究创新和研究生办公室,GTIIT传媒与公共事务部

Text/Photos: RIGS, GTIIT News & Public Affairs




延伸阅读
  • 成都疫情2022年9月5日成都高新区全员核酸检测通知

    成都高新区新冠肺炎疫情防控指挥部关于继续做好全员核酸检测的温馨提示各位市民朋友:为继续做好成都市全员核酸检测工作,现将有关事项提示如下:一、成都高新区将于9月5日-9月7日继续开展全员核酸检测,每日采

  • 菏泽疫情最新消息2022年9月5日

    菏泽连续3天无新增病例新增本土0新增本土无症状0现有确诊0累计确诊37累计治愈37累计死亡0新增数据统计周期为昨日09.04 0-24时本地播报09月04日  09:509月3日菏泽市无新增本土病例0

  • 无锡疫情2022年8月25日

    无锡连续1个月无本土新增新增本土0新增本土无症状0现有确诊0累计确诊103累计治愈103累计死亡0新增数据统计周期为昨日08.24 0-24时本地播报08月19日  11:49无锡江阴发布疫情防控通告

关注公众号:拾黑(shiheibook)了解更多

友情链接:

关注数据与安全,洞悉企业级服务市场:https://www.ijiandao.com/
安全、绿色软件下载就上极速下载站:https://www.yaorank.com/
找律师打官司就上碳链网:https://www.itanlian.com/

限时推广:让每一个问题都有答案:https://ask.0xu.cn
公众号 关注网络尖刀微信公众号
随时掌握互联网精彩
赞助链接